<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>dgkh000515</Identifier>
    <IdentifierDoi>10.3205/dgkh000515</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-dgkh0005154</IdentifierUrn>
    <ArticleType>Research Article</ArticleType>
    <TitleGroup>
      <Title language="en">Investigating the properties and antibacterial, antioxidant, and cytotoxicity activity of postbiotics derived from Lacticaseibacillus casei on various gastrointestinal pathogens in vitro and in food models</Title>
      <TitleTranslated language="de">Untersuchung der Eigenschaften und der antibakteriellen, antioxidativen und zytotoxischen Wirkung von Postbiotika aus Lactaseibacillus casei auf einige gastrointestinale Krankheitserreger in vitro und in Lebensmittelmodellen</TitleTranslated>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Asadi</Lastname>
          <LastnameHeading>Asadi</LastnameHeading>
          <Firstname>Zahra</Firstname>
          <Initials>Z</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Abbasi</Lastname>
          <LastnameHeading>Abbasi</LastnameHeading>
          <Firstname>Amin</Firstname>
          <Initials>A</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Ghaemi</Lastname>
          <LastnameHeading>Ghaemi</LastnameHeading>
          <Firstname>Ali</Firstname>
          <Initials>A</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Montazeri</Lastname>
          <LastnameHeading>Montazeri</LastnameHeading>
          <Firstname>Effat Abbasi</Firstname>
          <Initials>EA</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Akrami</Lastname>
          <LastnameHeading>Akrami</LastnameHeading>
          <Firstname>Sousan</Firstname>
          <Initials>S</Initials>
          <AcademicTitleSuffix>PhD</AcademicTitleSuffix>
        </PersonNames>
        <Address>Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Poursina street , Tehran, Iran, Phone: &#43;98 9166060300<Affiliation>Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</Affiliation><Affiliation>Students&#39; Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran</Affiliation></Address>
        <Email>s.akrami1992&#64;gmail.com</Email>
        <Creatorrole corresponding="yes" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
      <Keyword language="en">cell-free supernatant probiotic</Keyword>
      <Keyword language="en">Lacticaseibacillus casei</Keyword>
      <Keyword language="en">antibacterial capacity</Keyword>
      <Keyword language="en">gas chromatography&#47;mass spectrometry</Keyword>
      <Keyword language="de">zellfreier probiotischer &#220;berstand</Keyword>
      <Keyword language="de">Lactaseibacillus casei</Keyword>
      <Keyword language="de">antibakterielle Kapazit&#228;t</Keyword>
      <Keyword language="de">Gaschromatographie-Massenspektrometrie</Keyword>
    </SubjectGroup>
    <DatePublishedList>
      
    <DatePublished>20241105</DatePublished></DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Journal>
        <ISSN>2196-5226</ISSN>
        <Volume>19</Volume>
        <JournalTitle>GMS Hygiene and Infection Control</JournalTitle>
        <JournalTitleAbbr>GMS Hyg Infect Control</JournalTitleAbbr>
      </Journal>
    </SourceGroup>
    <ArticleNo>60</ArticleNo>
  </MetaData>
  <OrigData>
    <Abstract language="de" linked="yes"><Pgraph><Mark1>Hintergrund:</Mark1> Postbiotika bestehen aus l&#246;slichen Verbindungen, die aus der Struktur zerst&#246;rter Bakterien freigesetzt oder von lebenden Bakterien erzeugt werden. Diese Nebenprodukte bieten dem Wirt eine verbesserte biologische Funktion mit spezifischen physiologischen Auswirkungen. Ziel der Untersuchung war es, die Eigenschaften und m&#246;glichen gesundheitlichen Vorteile von Postbiotika aus L<Mark2>actaseibacillus (L.) casei</Mark2> zu untersuchen.</Pgraph><Pgraph><Mark1>Methode:</Mark1> Die antibakterielle Wirkung von Postbiotika aus <Mark2>L. casei</Mark2> wurde in vitro sowie in pasteurisierter Milch und Hackfleisch gegen verschiedene gastrointestinale Infektionserreger untersucht. Die Wirksamkeit der Postbiotika wurde mithilfe des Agardiffusionstests (Scheibchen- und Lochtest), der Bestimmung der minimalen Hemmkonzentration und der minimalen bakteriziden Konzentration bewertet. Die Postbiotika wurden auf antioxidative Aktivit&#228;t gegen 2,2-Azinobis<TextGroup><PlainText>(3-eth</PlainText></TextGroup>ylbenzothiazolin-6-sulfons&#228;ure) (ABTS)-freie Radikale getestet. Zus&#228;tzlich wurde der Gesamtphenol- und Flavonoidgehalt der Postbiotika bestimmt. Der kolorimetrische MTT-Assay wurde verwendet, um die potenzielle Zytotoxizit&#228;t von Postbiotika zu untersuchen. Die chemische Zusammensetzung der Postbiotika wurde mithilfe der Gaschromatographie-Massenspektrometrie bestimmt.</Pgraph><Pgraph><Mark1>Ergebnisse:</Mark1> Die antibakterielle Wirksamkeitt war haupts&#228;chlich auf Pyrrolo&#91;1,2-a&#93;pyrazin-1,4-dion, Benzoes&#228;ure und Laurostearins&#228;ure zur&#252;ckzuf&#252;hren. Grampositive Bakterien wurden in vitro st&#228;rker von den mikrobiellen Nebenprodukten beeinflusst als Gramnegative Bakterien (P&#60;0,05). Die minimal wirksamen Konzentrationen von Postbiotika waren in Hackfleisch und Milch im mit Listeria monocytogenes inokulierten Modell viel h&#246;her als mit anderen Bakterien (P&#60;0,05). Postbiotika zeigen auch eine hohe antioxidative Aktivit&#228;t. Aus <Mark2>L. casei</Mark2> erzeugte Postbiotika hatten die h&#246;chsten Konzentrationen an phenolischen (99,46 mg GAE&#47;g) und flavonoiden (17,46 mg QE&#47;g) Bestandteilen. Postbiotika hatten in keiner Dosis Einfluss auf die Lebensf&#228;higkeit menschlicher Vorhautfibroblasten.</Pgraph><Pgraph><Mark1>Schlussfolgerung:</Mark1> Postbiotika von <Mark2>Lactobacillus</Mark2> spp., insbesondere aus <Mark2>L. casei</Mark2>, werden aufgrund ihrer w&#252;nschenswerten Wirkungen und biologischen Eigenschaften zur Verwendung als Antioxidantien, antimikrobielle Mittel und Konservierungsmittel sowohl im Lebensmittel- als auch im Pharmasektor empfohlen.</Pgraph></Abstract>
    <Abstract language="en" linked="yes"><Pgraph><Mark1>Background:</Mark1> Postbiotics comprise soluble compounds freed from the structure of destroyed bacteria or created by living bacteria. Such byproducts provide the host with enhanced biological function as well as specific physiological consequences. This research aims to examine the characteristics and possible health advantages of <Mark2>Lacticaseibacillus (L.) casei</Mark2>-derived postbiotics. </Pgraph><Pgraph><Mark1>Methods:</Mark1> The antibacterial effects of postbiotics derived from <Mark2>L. casei</Mark2> were examined in vitro against various infectious gastrointestinal agents, as well as pasteurized milk and minced beef. Postbiotic activity potential was evaluated using disc-diffusion agar, minimum inhibitory concentration, minimum bactericidal concentration, and well-diffusion agar methods. Postbiotics were tested for antioxidant activity against <TextGroup><PlainText>2,2-a</PlainText></TextGroup>zinobis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) free radicals. Additionally, the total phenolic and flavonoid content of the postbiotics was determined. The colorimetric MTT was used to investigate the potential cytotoxicity of postbiotics. The chemical makeup of the postbiotics was also determined using gas chromatography&#47;mass spectrometry. </Pgraph><Pgraph><Mark1>Results:</Mark1> The antibacterial capacity was mostly related to pyrrolo&#91;1,2-a&#93; pyrazine-1,4-dione, benzoic acid, and laurostearic acid. Gram-positive microbes were more influenced by microbial byproducts in vitro than Gram-negative bacteria (P&#60;0.05). The minimum effective concentrations of postbiotics were found to be much greater in ground beef and milk in the <Mark2>Listeria monocytogenes</Mark2>-inoculated model than with other bacteria (P&#60;0.05). Postbiotics also show high antioxidant activity. Postbiotics generated from <Mark2>L. casei</Mark2> had the greatest concentrations of phenolic (99.46 mg GAE&#47;g) and flavonoid (17.46 mg QE&#47;g) constituents. Postbiotics had no influence on the viability of human foreskin fibroblasts at any dose. </Pgraph><Pgraph><Mark1>Conclusion:</Mark1> <Mark2>Lactobacillus</Mark2> spp. postbiotics, particularly <Mark2>L. casei</Mark2>, were recommended for use as antioxidants, antimicrobials, and preservatives in both the food and pharmaceuticals sector for their beneficial effects and biological properties.</Pgraph></Abstract>
    <TextBlock linked="yes" name="Introduction">
      <MainHeadline>Introduction</MainHeadline><Pgraph>Over the last few decades, researchers have paid special attention to prebiotics, probiotics, and postbiotics. They are acquired from many sources (for example, fruit, vegetables, and dairy products) and employed in a variety of foods and beverages because of their therapeutic benefits <TextLink reference="1"></TextLink>, e.g., enhancing the shelf life of foods. Functional foods have been created using probiotics and prebiotics, and in response to customer desire for chemical-free meals, a recent developing trend in the application of postbiotics in diverse foods has evolved. Furthermore, the use of probiotics in meals has been shown to have certain benefits <TextLink reference="2"></TextLink>. Postbiotics, for instance, are more resistant to food processing and may survive for a lengthy amount of time. The use of live probiotic bacteria in comestibles has its own set of constraints. Food type, pH, temperature, and other factors have a significant impact on live probiotic bacteria. Massive quantities of prebiotics and probiotics are being used in the food industry to manufacture functional foods, extend shelf life, and improve food safety <TextLink reference="3"></TextLink>.</Pgraph><Pgraph>Producer strains of bacterial and fungal species <Mark2>(Lactobacillus</Mark2>, <Mark2>Bifidobacterium</Mark2>, <Mark2>Streptococcus</Mark2>, <Mark2>Akkermansia</Mark2> <Mark2>muciniphila</Mark2>, <Mark2>Saccharomyces</Mark2> <Mark2>boulardii</Mark2>, <Mark2>Eubacterium</Mark2> <Mark2>hallii</Mark2>, <Mark2>Faecalibacterium</Mark2>, etc.) from which postbiotics are recovered in situ can be found naturally in a variety of fermented foods <TextLink reference="4"></TextLink>. As researchers discovered a relationship between the microbiome and immune support as well as overall health in recent years, gut health and dietary items that promote gut health have piqued the public&#8217;s attention. Postbiotics are the most recent contribution to the discussion about gut health <TextLink reference="5"></TextLink>. Whenever prebiotics are consumed, gastrointestinal microbes digest them, producing beneficial postbiotics as a result <TextLink reference="6"></TextLink>.</Pgraph><Pgraph><Mark2>L. casei</Mark2> is one such helpful bacterium that has been found to create a variety of postbiotics with a range of advantages <TextLink reference="7"></TextLink>. Organic acids (such as lactic acid), bacteriocins (antimicrobial peptides), exopolysaccharides (complex sugars), and some enzymes are examples of postbiotics generated from <Mark2>L. casei</Mark2>. These postbiotics are expected to add to the general health-promoting benefits of <Mark2>L. casei</Mark2> probiotic supplements or fermented foods <TextLink reference="8"></TextLink>. Postbiotics generated from <Mark2>L. casei</Mark2> have been proven in studies to have anti-inflammatory, immune-modulating, and antibacterial properties. They have also been shown to increase intestinal barrier integrity, lower oxidative stress, and boost nutritional absorption <TextLink reference="9"></TextLink>. In general, <Mark2>L. casei</Mark2> postbiotics offer a viable path for the creation of novel functional foods and nutraceuticals that might improve health and promote disease prevention <TextLink reference="10"></TextLink>.</Pgraph><Pgraph>The <Mark2>L. casei</Mark2> strain has been studied less than other lactic acid bacteria. This study investigated the antibacterial, antioxidant, and cytotoxicity activities of these postbiotics on numerous gastrointestinal microorganisms in vitro and in food models. The intention was to obtain a better understanding of their potential as a natural cure for numerous digestive problems by studying the impact of these postbiotics on bacteria typically present in the human gut. Furthermore, we looked at whether these postbiotics may serve as antioxidants, which could provide further general-health advantages. Finally, we investigated the cytotoxicity of these postbiotics in order to identify any possible dangers related to their usage.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Materials and methods">
      <MainHeadline>Materials and methods</MainHeadline><SubHeadline>Materials</SubHeadline><Pgraph>Merck Millipore (Darmstadt, Germany) provided the yeast peptone dextrose (YPD), yeast malt broth (YMB), agar-agar, 100&#37; ethanol, and chloroform. Sigma-Aldrich Co (St Louis, MO, USA) provided the ABTS (2,2&#39;-azino-bis <TextGroup><PlainText>&#91;3-et</PlainText></TextGroup>hylbenzothiazoline-6-sulfonic acid&#93; diammoniu<TextGroup><PlainText>m s</PlainText></TextGroup>alt), gallic acid, and quercetin. Mueller Hinton agar (MHA), Mueller Hinton broth (MHB), Sabouraud dextrose agar (SDA), mannitol salt agar (MSA), eosin methylene blue (EMB), plate count agar (PCA), brain heart infusion (BHI), Luria Bertani (LB), and cefixime tellurite sorbitol MacConkey (CT-SMAC) were all obtained from Merck Millipore.</Pgraph><SubHeadline>Preparation and maintenance of probiotic yeast strain</SubHeadline><Pgraph>Persian Type Culture Collection (Iranian Research Organization for Science and Technology) supplied <Mark2>L. casei</Mark2> (PTCC 1608) and was cultivated in YPD (20 g&#47;L dextrose, 4 g&#47;L yeast extract, 3 g&#47;L bacterial peptone, 2 g&#47;L Tri ammonium citrate, 1 g&#47;L polysorbate 80, 1 g&#47;L KH2PO4, and 0.8 g&#47;L MgSO4) for 24&#8211;48 h at 30&#176;C while being stirred at 200 rpm. If necessary, <Mark2>L. casei</Mark2> suspensions were standardized using a spectrophotometer (Shimadzu UV3600, Japan) in the 600-nm (ultraviolet) wavelength range.</Pgraph><SubHeadline>Preparation of yeast cell-free supernatant solution</SubHeadline><Pgraph>The aerobic cultivation of <Mark2>L. casei</Mark2> in YMB for 48 hours at 37&#176;C is the initial step in the production of cell-free supernatant (CFS) postbiotics. Because varied microbial strain growth conditions and extraction methodologies have a major impact on postbiotic efficacy, this approach was carried out in 2,000-mL Erlenmeyer flasks to obtain adequate and suitable amounts of CFSs. In brief, CFS was extracted after 24&#8211;48 hours of incubation at 37&#176;C, followed by 10 minutes of centrifugation at 4&#176;C and 4,500 rpm. Before treating the samples, the yeast medium supernatant was collected, the pH was adjusted to 7.2, and it was filtered through a 0.22-m Millipore filter (Sigma-Aldrich, Millipore Sigma Co., Germany). The filtrate was collected in order to freeze-dry it. The extracted CFS were then frozen for 24 hours at &#8211;80&#176;C. From 40&#176;C to 30&#176;C, at 0.2 mbar, the CFS was lyophilized (Lyophilization Systems, Inc, USA). The entire freeze-drying procedure took 24 hours, and the freeze-dried powders were kept at 20&#176;C. Prior to usage, they were rehydrated with sterile, deionized water.</Pgraph><SubHeadline>Gas chromatography&#47;mass spectroscopy (GC&#47;MS)</SubHeadline><Pgraph>By using a mass spectrometer (Agilent Technologies 5975C, USA) in conjunction with a gas chromatograph (Agilent Technologies 7890A, USA), the primary chemical constituents of postbiotics that originate from <TextGroup><Mark2>Lacticaseibacillus</Mark2></TextGroup><Mark2> casei</Mark2> (PLC) were identified and quantified. A capillary column (with dimensions of <TextGroup><PlainText>30 m&#215;0.25 mm&#215;0</PlainText></TextGroup>.25 &#181;m) was injected with PLC (0.<TextGroup><PlainText>1 &#181;</PlainText></TextGroup>L), and its temperature was raised from 45&#176;C to 210&#176;C at a rate of 3&#176;C&#47;min. The ionization energy was fixed at 7<TextGroup><PlainText>0 e</PlainText></TextGroup>V, and the helium gas flow rate was 1 mL&#47;min. </Pgraph><SubHeadline>Assessment of the Total Phenol Content</SubHeadline><Pgraph>Folin-Ciocalteu reagent was used to assess the total phenolic content of the PLC using a method established by Abeysekera et al. <TextLink reference="11"></TextLink>. The Folin-Ciocalteu reagent (110 &#181;L) and sodium carbonate solution (70 &#181;L) were used to charge the PLC (20 &#181;L). After 30 minutes at 25&#176;C, the mixture&#8217;s absorbance was measured at 765 nm. Gallic acid (0.06&#8211;1 mg&#47;mL) was used to create the standard curve, and the total phenol content of PLC was determined as mg gallic acid equivalent (GAE)&#47;g PLC.</Pgraph><SubHeadline>Assessment of the total flavonoid content</SubHeadline><Pgraph>The total flavonoid content of PLC was assessed using the aluminum chloride method. The mixture of PLC (10<TextGroup><PlainText>0 &#181;L</PlainText></TextGroup>) and aluminium chloride (100 &#181;L; 2&#37; w&#47;v in methanol) was incubated at 25&#176;C for 10 minutes before the absorbance at 367 nm was measured. The calibration curve was created using quercetin (7.81&#8211;125 mg&#47;mL), and the total flavonoid content was reported as mg quercetin equivalent (QE)&#47;g PLC <TextLink reference="11"></TextLink>.</Pgraph><SubHeadline>Antioxidant activity</SubHeadline><Pgraph>PLC&#8217;s antioxidant capacity was evaluated in relation to ABTS free radicals. The oxidation of 2.45 mM K<Subscript>2</Subscript>S<Subscript>2</Subscript>O<Subscript>8</Subscript> with a 7 mM ABTS solution produced the ABTS radical monocation. The combination was kept at room temperature for 12 hours in a dark environment before being diluted with ethanol to achieve 0.70.2 absorbance at 750 nm. The ABTS solution (1.8 mL) was then mixed with the PLC or control (0.2 mL), and the mixture&#8217;s absorbance at 75<TextGroup><PlainText>0 n</PlainText></TextGroup>m was measured using a spectrophotometer. Following is a calculation of CZEO&#8217;s antioxidant activity (Equation 1):</Pgraph><Pgraph><ImgLink imgNo="1" imgType="inlineFigure"/></Pgraph><SubHeadline>Antibacterial activity assessment of the prepared postbiotics in vitro</SubHeadline><Pgraph>The antibacterial effectiveness of the postbiotics was evaluated using the disc-diffusion agar (DDA) method, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and well-diffusion agar (WDA) against <Mark2>Salmonella</Mark2> <Mark2>typhi</Mark2> ATCC 6539, <Mark2>Escherichia</Mark2> <Mark2>coli</Mark2> ATCC 25922, <Mark2>Streptococcus</Mark2> <Mark2>mutans</Mark2> ATCC 25175, <Mark2>Clostridium</Mark2> <Mark2>difficile</Mark2> ATCC 9689, and <Mark2>Listeria</Mark2> <Mark2>monocytogenes</Mark2> ATCC 19112. The antibacterial properties of tetracycline, gentamicin, and chloramphenicol were compared in the DDA test.</Pgraph><SubHeadline>Antibacterial activity assessment of the prepared postbiotics in food models</SubHeadline><Pgraph>According to Hartmann et al. <TextLink reference="12"></TextLink>, the minimum effective concentration (MEC) of postbiotics was determined in the same way. <Mark2>E</Mark2>. <Mark2>coli</Mark2> ATCC 25922 and <Mark2>L</Mark2>. <Mark2>monocytogenes</Mark2> ATCC19112 were added to 10 mL of pasteurized milk in a bottle and 100 g of ground meat in sterile wrappers, respectively, to bring the final population to an appropriate level (&#126;3.2 and 4.1 (<Mark2>E. coli</Mark2>), 3.5 and 4.6 (<Mark2>L. monocytogenes</Mark2>) lg colony forming units (CFU)&#47;mL or gram of milk and meat, respectively). PLC was added to the milk and meat samples at concentrations ranging from 10 to 6<TextGroup><PlainText>0 m</PlainText></TextGroup>g&#47;mL, and each sample was completely homogeneous. All samples were kept at 4&#176;C for six days. Utilizing PALCAM Listeria Selective Agar and Cefixime Tellurite Sorbitol MacConkey agar, the studied pathogens were cultivated and counted. MEC was defined as the PLC concentration that decreases the initial microbial population to below the culture limit of 10 bacteria for milk and 100 bacteria for meat over the course of three days at 4&#176;C. Instead of a food matrix, comparable experiments were conducted using BHI broth and LB broth. Assays were performed in triplicate.</Pgraph><SubHeadline>Cytotoxicity of the postbiotics</SubHeadline><Pgraph>Human foreskin fibroblasts (HFF) were used to evaluate the possible toxicity of postbiotics of <Mark2>L</Mark2>. <Mark2>casei</Mark2> using the colorimetric MTT &#91;3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide&#93; test. HFF cells were exposed to PLC at various doses for the predetermined amount of time (24 h) (1x10<Superscript>5</Superscript> cells&#47;0.3 mL DMEM cell culture medium in 96-well plates). After 24 hours, the medium was withdrawn, and MTT solution was added to the cells in each microplate (0.2 mL; 3 mg&#47;mL). The MTT solution was removed after 3 hours of incubation at 37&#176;C, and formazan was then solubilized by adding 100 &#181;L&#47;well of lysis buffer. Using a microplate reader (Bio-Rad Model 3550), optical density (OD) was assessed at 570 nm after the plate had been shaken. The percentage of untreated (controls) cells was used to express cell viability as follows (Equation 2):</Pgraph><Pgraph><ImgLink imgNo="2" imgType="inlineFigure"/></Pgraph><SubHeadline>Statistical analysis</SubHeadline><Pgraph>All data were analyzed using GraphPad Prism (GraphPadSoftware; San Diego, California, USA). Levene&#8217;s test was carried out to ensure the equality of variances. Results are shown as mean&#177; SD (n&#61;3). The threshold for significance was set at P&#60;0.05.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Results">
      <MainHeadline>Results</MainHeadline><SubHeadline>Chemical composition of postbiotics</SubHeadline><Pgraph>Table 1 <ImgLink imgNo="1" imgType="table"/> displays the chemical profiles, retention times, and major constituent percentages (&#62;1&#37;) of postbiotics from <Mark2>L. casei</Mark2>. Organic acids, peptides, substances comprising fatty acids, alcohols, esters, and aldehydes in various forms and concentrations were abundant in postbiotics. The ipostbiotics examined were found to contain pyrrolo&#91;1,2-a&#93; pyrazine-1,4-dione, benzoic acid, and 5,10-diethoxy-2,3,7,8-tetrahydro-1H,6H-dipyrrolo&#91;1,2-a:1&#39;,2&#39;-d&#93;pyrazine. These substances are well-known for their antibacterial and antioxidant properties <TextLink reference="13"></TextLink>. Among the substances detected, postbiotic metabolites contained laurostearic acid, a waxy, 18-carbon-chain, saturated fatty acid. Laurostearic acid may function as a biosurfactant and aid in clearing the surface of the pathogen biofilm <TextLink reference="14"></TextLink>. Additionally, the presence of 1, 4-diaza-2, 5-dioxo-3-isobutyl bicyclo&#91;4.3.0&#93;nonane among the detected chemicals may point to the generated postbiotic solution&#8217;s possible anti-biofilm and antimicrobial effect <TextLink reference="15"></TextLink>. Another substance with promising antibacterial and anti-inflammatory characteristics is ergotaman-3&#39;,6&#39;,18-trione, 12&#39;-hydroxy-2&#39;-methyl-5&#39;-(phenylmethyl)-, (5&#39;alpha) <TextLink reference="16"></TextLink>. One of the characteristics of lactic acid bacteria is the formation of organic acids, such as lactic acid and acetic acid. Although certain organic acids were present, lactic acid was not among the postbiotic metabolites that were analysed. The findings of the experiments demonstrated that the type and composition of individual chemicals are significantly influenced by the technique used for analysis.</Pgraph><SubHeadline>Total phenols and flavonoids of the prepared postbiotics</SubHeadline><Pgraph>The PLC contains significant amounts of flavonoids (17.4<TextGroup><PlainText>6 m</PlainText></TextGroup>g QE&#47;g) and phenolics (99.46&#177;0.12 mg GAE&#47;g) (P&#60;0.05). Indeed, growth and extraction conditions, coupled with basic stock preparation techniques, have an impact on the content and quality of the final produced PLC solution. The studied PLC had significant amounts of phenolic and flavonoid compounds when all of the active components were taken into account.</Pgraph><SubHeadline>Antioxidant activity</SubHeadline><Pgraph>Due to the fact that polyphenols contain natural redox capabilities that can neutralize free radicals, these bioactive substances have the ability to strengthen the immune system while also providing preventative benefits for a number of degenerative illnesses, including diabetes and cardiovascular disease <TextLink reference="17"></TextLink>. The direct oxidation of ABTS with K<Subscript>2</Subscript>S<Subscript>2</Subscript>O<Subscript>8</Subscript> results in a stable, blue-green ABTS&#9679;&#43;, which is the basis for the ABTS test. The amount of the radical solution&#8217;s decolorization (reduction) is then measured at 750 nm when antioxidants are present <TextLink reference="18"></TextLink>. The PLC&#8217;s antioxidant activity was quite high (70.41&#43;0.43&#37;). Phenols, flavonoids, and the primary chemical components of the PLC all contribute to this exceptionally strong antioxidant action <TextLink reference="19"></TextLink>. Some research has demonstrated the PLC&#8217;s antioxidant ability. As a result, the PLC might be employed to slow down or stop the oxidative damaging effects of free radical processes. </Pgraph><SubHeadline>Antibacterial activity of the prepared postbiotics in vitro</SubHeadline><Pgraph>This study used antimicrobial tests, including DDA, WDA, MIC, and MBC against harmful bacterial species to assess the PLC&#8217;s antibacterial potential. The antibacterial action of the PLC varied depending on the yeast types, and Gram-positive bacteria were more commonly impacted by microbial byproducts than were Gram-negative bacteria (Table 2 <ImgLink imgNo="2" imgType="table"/> and Table 3 <ImgLink imgNo="3" imgType="table"/>). In the DDA and WDA tests, the mean inhibition zones for Gram-positive bacteria were 19.61 mm and 23.24 mm, respectively, whereas the mean inhibition zones for Gram-negative bacteria were 10.90 mm and 15.16 mm, respectively. The MIC and MBC experiments produced similar results, and less PLC was needed to kill or stop the growth of Gram-positive bacteria than Gram-negative bacteria (Table 3 <ImgLink imgNo="3" imgType="table"/>).</Pgraph><SubHeadline>Antibacterial activity of the prepared postbiotics in food models</SubHeadline><Pgraph>The amount of an antimicrobial agent that must be present for it to be effective at preventing the growth of a pathogen in a food product is known as the minimum effective concentration (MEC). The estimated MECs of PLC against <Mark2>L. monocytogenes</Mark2> and <Mark2>E. coli</Mark2> in various challenge matrices are shown in Table 4 <ImgLink imgNo="4" imgType="table"/>. In the <TextGroup><Mark2>L. m</Mark2></TextGroup><Mark2>onocytogenes</Mark2> inoculation model, the MECs of PLC were much higher in milk and ground beef, although the MECs varied greatly among the different dietary models. When exposed to an <Mark2>E. coli</Mark2>-infected model, PLC demonstrated little antibacterial activity (50 mg&#47;mL in food models), which is comparable to <Mark2>in vitro</Mark2> settings. The influence of structural variations between Gram-positive and Gram-negative bacteria on the antibacterial capabilities of PLC was brought to light by this. </Pgraph><SubHeadline>Cytotoxicity of postbiotics</SubHeadline><Pgraph>PLC did not show any cytotoxic effect at any concentration on the viability of HFF. Interestingly, PLC simulated the growth of HFF cells at high concentrations (100 and 1,000 &#181;g&#47;mL). Additionally, a dose-dependent cytotoxic effect has been reported on myeloma cells proliferation for the suspensions of L. salivarius HA8 and Enterococcus faecium CH3 <TextLink reference="20"></TextLink>. </Pgraph></TextBlock>
    <TextBlock linked="yes" name="Discussion">
      <MainHeadline>Discussion</MainHeadline><Pgraph>Bioactive chemicals such as probiotics, prebiotics, and postbiotics have received much attention in recent decades. These substances are associated with the beneficial gut microbiota and promote host health. Postbiotics are live probiotic components that can execute the biological and physiological tasks of their natural parent organisms <TextLink reference="21"></TextLink>. Postbiotics often exhibit their health and therapeutic benefits via modes of action that are comparable to or distinct from those of their predecessors. Postbiotics are less susceptible to processing circumstances, environmental influences, and gastrointestinal conditions than probiotics, which increases their commercial viability <TextLink reference="22"></TextLink>. <Mark2>Salmonella typhi</Mark2>, <Mark2>Escherichia coli</Mark2>, <Mark2>Streptococcus mutans</Mark2>, <Mark2>Clostridioidis (C.) difficile</Mark2>, and <Mark2>Listeria monocytogenes</Mark2> are known to cause foodborne illnesses in humans. These microorganisms can infect food due to a variety of factors, including poor sanitation practices during the preparation of food, insufficient cooking, and incorrect storage conditions. <Mark2>S. typhi</Mark2> produces typhoid fever, a kind of food poisoning marked by symptoms including high fever, stomach discomfort, and diarrhea <TextLink reference="23"></TextLink>. <Mark2>E. co</Mark2>li is a prevalent source of food-related illness that can cause stomach discomfort, diarrhea, and nausea. <Mark2>S. mutans</Mark2> is frequently linked to dental caries <TextLink reference="24"></TextLink>. <Mark2>C. difficile</Mark2> has been linked to major diarrhea and colitis, while <Mark2>Listeria monocytogenes</Mark2> can cause listeriosis, a potentially fatal infection of the brain and spine <TextLink reference="25"></TextLink>. Because its environment becomes acidic during its growth, the antibacterial activity of <Mark2>L. casei</Mark2> supernatant can be related to the generation of organic acids: pathogenic organisms which are susceptible to acidic environments are destroyed <TextLink reference="26"></TextLink>. Many infections have been demonstrated to cause malignancy in humans <TextLink reference="27"></TextLink>. Salmonella and gallbladder cancer have been linked in studies. The host&#8217;s health is substantially influenced by the gut flora <TextLink reference="28"></TextLink>. For instance, a heat-killed <Mark2>L. delbrueckii</Mark2>-supplemented diet stimulates the establishment of desirable <Mark2>Bifidobacterium</Mark2> spp. and related metabolic alterations in the individual&#39;s fermented fecal population <TextLink reference="29"></TextLink>. Short-chain fatty acids maintain the pH of the human stomach at 5-6, limiting detrimental bacteria while enabling health-promoting bacteria to grow <TextLink reference="30"></TextLink>. According to Kotani et al.,<Mark2> L. rhamnosus</Mark2> inhibited the dehydration and oxidation of bile acids by lowering the activity of <TextGroup><PlainText>&#946;-g</PlainText></TextGroup>lucuronidase, hence suppressing microbial enzymes <TextLink reference="31"></TextLink>. Furthermore, <Mark2>L. plantarum</Mark2> b240 inhibited the invasion and adhesion of bacterial pathogens onto intestinal epithelial cell surfaces. A postbiotic-rich diet has the ability to change the substance, variety, and richness of the gut microbiota <TextLink reference="31"></TextLink>. This study performed antimicrobial assays such as DDA, WDA, MIC, and MBC against spoilage and dangerous bacterial species to evaluate the PLC&#8217;s antibacterial properties. Based on the findings of the DDA and WDA tests, <Mark2>L. monocytogenes</Mark2> and <Mark2>E. coli</Mark2> exhibited the largest and smallest inhibition zones, respectively, for the antibacterial activity of the PLC. Furthermore, the inhibitory zone resulting from the WDA technique was much larger than that of the DDA test. This is partly due to the fact that the former technique directly interacts with the bacterial species, while the latter does not <TextLink reference="32"></TextLink>. A synergistic effect of PLC and antibiotics is also worth noting; this combination exhibited atypically better antibacterial effects than the PLC alone (Table 2 <ImgLink imgNo="2" imgType="table"/>). In this investigation, Gram-positive bacteria required less PLC to be killed or stop growing than did Gram-negative bacteria. Based on the MIC and MBC data, these differences have been linked to variances in the bacterial cell wall structure. Lipoproteins and lipopolysaccharides are major components of Gram-negative bacterial walls, which contribute to their superior resistance to antimicrobial agents <TextLink reference="18"></TextLink>.</Pgraph><Pgraph>High amounts of reactive oxygen species and free radicals expose biological systems to oxidative stress. The existence of oxidative stress has been linked to a number of disorders, including cancer, cirrhosis of the liver, and fatty liver <TextLink reference="33"></TextLink>. Exopolysaccharides (EPSs) from lactic acid bacteria (LAB) were found to help eliminate free radicals, functioning as natural powerful antioxidants. They have also been shown to be non-toxic, implying that they might be utilized as a substitute for synthetic antioxidants, which pose certain hazards <TextLink reference="34"></TextLink>&#63; In the current investigation, PLC has a significantly higher antioxidant activity (70.41&#177;0.43&#37;). In-vitro and <Mark2>in vivo</Mark2> research have extensively explored the good antioxidant activity of LAB-derived EPSs. Dilna et al. <TextLink reference="33"></TextLink> isolated EPS from L. plantarum RJF4, which comprised glucose and mannose. EPS boosted overall antioxidant effectiveness by 32&#37;, radical scavenging efficiency by 24&#37;, and reduction potential by 50&#37; (when compared to ascorbic acid as a benchmark). EPS from <Mark2>L. acidophilus</Mark2> demonstrated strong in-vitro antioxidative action on lines of colon cancer cells in DPPH (2,2-diphenyl-1-picrylhydrazyl) -radical scavenging, reducing power, and ferric reducing antioxidant power (FRAP) tests. In all of these experiments, raising the concentration of EPS increased its antioxidative properties <TextLink reference="35"></TextLink>.</Pgraph><Pgraph>In recent years, functional foods including probiotics, prebiotics, and postbiotics have attracted increasing interest of researchers, producers, and consumers. There is currently a large range of bioactive food items on the market, such as probiotics, dairy, and non-dairy products, to meet the nutritional demands of consumers with varied dietary needs and choices, such as those who are allergic to milk proteins, lactose intolerant, and vegetarians. Because postbiotics are stable throughout a wide temperature and pH range, they can be added before thermal processing without impairing their functionality. This may provide producers with certain technical and economic benefits <TextLink reference="36"></TextLink>. In the present study, the MECs of PLC were shown to be considerably greater in ground beef and milk in the <Mark2>L. monocytogenes</Mark2> inoculation model. According to Ahmad Rather et al., the postbiotic supernatant of <TextGroup><Mark2>L. pl</Mark2></TextGroup><Mark2>antarum</Mark2> YML007 can be used as a bio-preservative, prolonging the shelf life of soybeans by up to two months <TextLink reference="37"></TextLink>. <Mark2>L. lactis</Mark2> subsp. <Mark2>lactis</Mark2> may generate nisin, which is used as a preservative in a variety of foods (infant formula, canned soups, and dairy products) <TextLink reference="38"></TextLink>. With the foregoing in mind, the use of foods as a delivery mechanism for postbiotics appears to be a promising but challenging endeavor. </Pgraph><Pgraph>PLC had no cytotoxic effect on the viability of HFF at any concentration. Furthermore, <Mark2>Lacticaseibacillus</Mark2> suspensions have been shown to have a cytotoxic effect on cancer cells. Cancer therapies are recognised to have limits and adverse effects, prompting researchers to look for alternate therapy options for generating innovative, safe and effective CRC remedies. Probiotics, prebiotics, synbiotics, paraprobiotics, and metabiotics or postbiotics are the most well-investigated options in this context <TextLink reference="39"></TextLink>. Elham et al. <TextLink reference="40"></TextLink> accumulated substantial data confirming the anti-colon cancer properties of <Mark2>L. casei</Mark2>. A dose-dependent cytotoxic impact was reported, with increasing concentrations of the fractions causing increased cytotoxicity in Caco-2 cells. Furthermore, several LAB strains have been discovered to have dose-dependent anticarcinogenic properties <TextLink reference="41"></TextLink>. Live probiotic cells have an impact on both the gastrointestinal microbiota and the immune response, whereas heat-killed cells have an anti-inflammatory effect on the gastrointestinal tract. <Mark2>Lacticaseibacillus</Mark2> spp. cell wall components are known to elicit an inflammatory response involving macrophages in the mammalian gastrointestinal tract <TextLink reference="40"></TextLink>. Another group of researchers <TextLink reference="42"></TextLink> reported that live and HK-sonic protein of <Mark2>L. casei</Mark2> induced cytotoxicity effects in vitro on CT-26 and HT-29 cells and were able to reduce the viability of murine CT-26 (colon cancer cell line) and human HT-29 (colon cancer cell line).</Pgraph><Pgraph>GC&#47;MS was used to identify and quantify the chemical makeup of PLC. Postbiotics are bioactive chemicals created following the development and metabolism of probiotic bacteria such as <Mark2>L. casei</Mark2>. The chemical makeup of postbiotics varies based on the <Mark2>L. casei</Mark2> strain, fermentation circumstances, and growth medium employed. Organic acids, bacteriocins (antimicrobial peptides), EPS, phenolic compounds, and enzymes are some of the most prevalent bioactive molecules observed in <Mark2>L. casei</Mark2> postbiotics. Several studies have reported on the chemical makeup of <Mark2>L. casei</Mark2> postbiotics generated under diverse settings <TextLink reference="8"></TextLink>. Overall, the chemical composition of postbiotics from <Mark2>L. casei</Mark2> is diverse and complex, and further research is needed to fully understand its potential health benefits.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Conclusions">
      <MainHeadline>Conclusions</MainHeadline><Pgraph><Mark2>Lacticaseibacillus</Mark2> products and by-products have been discovered to have several therapeutic roles, including epithelial barrier maintenance, anti-tumor impact, immunomodulation, and antagonistic actions against infections. Furthermore, they offer some benefits over probiotics, such as clear chemical structures, safety dosing guidelines, and a longer shelf life. Postbiotics are increasingly being used in the human food, animal feed, and pharmaceutical sectors, and various paraprobiotic and postbiotic products generated from <Mark2>Lactobacill</Mark2> species are commercially accessible for disease prevention or treatment. Nonetheless, further data are required to establish postbiotics&#8217; positive benefits. According to the findings of this study, postbiotic metabolites derived from <Mark2>Lacticaseibacillus casei</Mark2> (PTCC 1608) have multiple health-promoting effects due to their significant antioxidant capacity (P&#60;0.05) and antibacterial action against both Gram-negative and Gram-positive bacteria. Also, they can cause significant cytotoxicity (P&#60;0.05) against and arrest the cell cycle of cancer cells. Therefore, would make sense to construct particular mixes of postbiotics with substantial efficiency by learning more about lactic acid bacteria, employing established and refined procedures for extraction, verification, characterization, and conducting metabolomic and proteomic research. This would significantly improve the performance of health-care systems in dealing with a wide range of acute and chronic disorders. Further research into postbiotics will generate fresh insights and various favorable impacts, allowing them to be used more widely in the food and pharmaceutical sectors. More research should be done to determine the factors, such as eating habits that may influence the use of these beneficial chemicals in functional foods. These initiatives will contribute to the manufacture of safe, natural, clean label goods that are also free of unwanted by-products, thus safeguarding human health. Essentially, a clean label means making a product using as few ingredients as possible and ensuring those ingredients are items that consumers recognize and think of as wholesome &#8211; ingredients that consumers might use at home.</Pgraph><Pgraph>Overall, we feel that this study provides useful information on the possible benefits and drawbacks of employing <TextGroup><Mark2>L. ca</Mark2></TextGroup><Mark2>sei</Mark2> postbiotics to promote digestion. We intend to pave the road for the creation of innovative and efficient natural therapies for diverse digestive illnesses by better understanding the characteristics and potential health advantages of these postbiotics.</Pgraph></TextBlock>
    <TextBlock linked="yes" name="Notes">
      <MainHeadline>Notes</MainHeadline><SubHeadline>Author&#8217;s ORCID</SubHeadline><Pgraph>Sousan Akrami: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0001-6643-140X">0000-0001-6643-140X</Hyperlink></Pgraph><SubHeadline>Ethical approval </SubHeadline><Pgraph>Protocols for collection of samples as well as the experimental design and all methods were performed in accordance with the guidelines and regulations of Ahvaz Jundishapur University of Medical Sciences and approved by the institutional ethical committees. The present research was supported by the Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (01s56) (No. IR.AJUMS.REC.1401.428).</Pgraph><SubHeadline>Funding </SubHeadline><Pgraph>This work was supported by grant number 01s56 from Vice Chancellor for Research, Ahvaz Jundishapur University of Medical Sciences, Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Pgraph><SubHeadline>Acknowledgments </SubHeadline><Pgraph>The present research was supported by the Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (01s56) (No. IR.AJUMS.REC.1401.428).</Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Diez-Gutierrez L</RefAuthor>
        <RefAuthor>San Vicente L</RefAuthor>
        <RefAuthor>Barron LJR</RefAuthor>
        <RefAuthor>del Carmen Villaran M</RefAuthor>
        <RefAuthor>Chavarri M</RefAuthor>
        <RefTitle>Gamma-aminobutyric acid and probiotics: Multiple health benefits and their future in the global functional food and nutraceuticals market</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>J Funct Foods</RefJournal>
        <RefPage>103669</RefPage>
        <RefTotal>Diez-Gutierrez L, San Vicente L, Barron LJR, del Carmen Villaran M, Chavarri M. Gamma-aminobutyric acid and probiotics: Multiple health benefits and their future in the global functional food and nutraceuticals market. J Funct Foods. 2020;64:103669. DOI: 10.1016&#47;j.jff.2019.103669</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jff.2019.103669</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Raman M</RefAuthor>
        <RefAuthor>Ambalam P</RefAuthor>
        <RefAuthor>Doble M</RefAuthor>
        <RefTitle>Probiotics, Prebiotics, and Fibers in Nutritive and Functional Beverages</RefTitle>
        <RefYear>2019</RefYear>
        <RefBookTitle>Nutrients in Beverages Vol 12: The Science of Beverages</RefBookTitle>
        <RefPage>315-67</RefPage>
        <RefTotal>Raman M, Ambalam P, Doble M. Probiotics, Prebiotics, and Fibers in Nutritive and Functional Beverages. In: Grumezescu AM, Holban AM, editors. Nutrients in Beverages Vol 12: The Science of Beverages. Duxford, UK: Woodhead Publishing (Elsevier); 2019. pp. 315-67. DOI: 10.1016&#47;B978-0-12-816842-4.00009-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;B978-0-12-816842-4.00009-5</RefLink>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Nataraj BH</RefAuthor>
        <RefAuthor>Ali SA</RefAuthor>
        <RefAuthor>Behare PV</RefAuthor>
        <RefAuthor>Yadav H</RefAuthor>
        <RefTitle>Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Microb Cell Fact</RefJournal>
        <RefPage>168</RefPage>
        <RefTotal>Nataraj BH, Ali SA, Behare PV, Yadav H. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microb Cell Fact. 2020 Aug 20;19(1):168. DOI: 10.1186&#47;s12934-020-01426-w</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12934-020-01426-w</RefLink>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>Thorakkattu P</RefAuthor>
        <RefAuthor>Khanashyam AC</RefAuthor>
        <RefAuthor>Shah K</RefAuthor>
        <RefAuthor>Babu KS</RefAuthor>
        <RefAuthor>Mundanat AS</RefAuthor>
        <RefAuthor>Deliephan A</RefAuthor>
        <RefAuthor>Deokar GS</RefAuthor>
        <RefAuthor>Santivarangkna C</RefAuthor>
        <RefAuthor>Nirmal NP</RefAuthor>
        <RefTitle>Postbiotics: Current Trends in Food and Pharmaceutical Industry</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Foods</RefJournal>
        <RefPage>3094</RefPage>
        <RefTotal>Thorakkattu P, Khanashyam AC, Shah K, Babu KS, Mundanat AS, Deliephan A, Deokar GS, Santivarangkna C, Nirmal NP. Postbiotics: Current Trends in Food and Pharmaceutical Industry. Foods. 2022 Oct 5;11(19):3094. DOI: 10.3390&#47;foods11193094</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;foods11193094</RefLink>
      </Reference>
      <Reference refNo="5">
        <RefAuthor>Li HY</RefAuthor>
        <RefAuthor>Zhou DD</RefAuthor>
        <RefAuthor>Gan RY</RefAuthor>
        <RefAuthor>Huang SY</RefAuthor>
        <RefAuthor>Zhao CN</RefAuthor>
        <RefAuthor>Shang A</RefAuthor>
        <RefAuthor>Xu XY</RefAuthor>
        <RefAuthor>Li HB</RefAuthor>
        <RefTitle>Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Nutrients</RefJournal>
        <RefPage>3211</RefPage>
        <RefTotal>Li HY, Zhou DD, Gan RY, Huang SY, Zhao CN, Shang A, Xu XY, Li HB. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients. 2021 Sep 15;13(9):3211. DOI: 10.3390&#47;nu13093211</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;nu13093211</RefLink>
      </Reference>
      <Reference refNo="6">
        <RefAuthor>Singh RP</RefAuthor>
        <RefTitle>Glycan utilisation system in Bacteroides and Bifidobacteria and their roles in gut stability and health</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Appl Microbiol Biotechnol</RefJournal>
        <RefPage>7287-315</RefPage>
        <RefTotal>Singh RP. Glycan utilisation system in Bacteroides and Bifidobacteria and their roles in gut stability and health. Appl Microbiol Biotechnol. 2019 Sep;103(18):7287-315. DOI: 10.1007&#47;s00253-019-10012-z</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00253-019-10012-z</RefLink>
      </Reference>
      <Reference refNo="7">
        <RefAuthor>Teame T</RefAuthor>
        <RefAuthor>Wang A</RefAuthor>
        <RefAuthor>Xie M</RefAuthor>
        <RefAuthor>Zhang Z</RefAuthor>
        <RefAuthor>Yang Y</RefAuthor>
        <RefAuthor>Ding Q</RefAuthor>
        <RefAuthor>Gao C</RefAuthor>
        <RefAuthor>Olsen RE</RefAuthor>
        <RefAuthor>Ran C</RefAuthor>
        <RefAuthor>Zhou Z</RefAuthor>
        <RefTitle>Paraprobiotics and Postbiotics of Probiotic Lactobacilli, Their Positive Effects on the Host and Action Mechanisms: A Review</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Front Nutr</RefJournal>
        <RefPage>570344</RefPage>
        <RefTotal>Teame T, Wang A, Xie M, Zhang Z, Yang Y, Ding Q, Gao C, Olsen RE, Ran C, Zhou Z. Paraprobiotics and Postbiotics of Probiotic Lactobacilli, Their Positive Effects on the Host and Action Mechanisms: A Review. Front Nutr. 2020 Oct 22;7:570344. DOI: 10.3389&#47;fnut.2020.570344</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3389&#47;fnut.2020.570344</RefLink>
      </Reference>
      <Reference refNo="8">
        <RefAuthor>Moradi M</RefAuthor>
        <RefAuthor>Kousheh SA</RefAuthor>
        <RefAuthor>Almasi H</RefAuthor>
        <RefAuthor>Alizadeh A</RefAuthor>
        <RefAuthor>Guimar&#227;es JT</RefAuthor>
        <RefAuthor>Y&#305;lmaz N</RefAuthor>
        <RefAuthor>Lotfi A</RefAuthor>
        <RefTitle>Postbiotics produced by lactic acid bacteria: The next frontier in food safety</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Compr Rev Food Sci Food Saf</RefJournal>
        <RefPage>3390-415</RefPage>
        <RefTotal>Moradi M, Kousheh SA, Almasi H, Alizadeh A, Guimar&#227;es JT, Y&#305;lmaz N, Lotfi A. Postbiotics produced by lactic acid bacteria: The next frontier in food safety. Compr Rev Food Sci Food Saf. 2020 Nov;19(6):3390-415. DOI: 10.1111&#47;1541-4337.12613</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;1541-4337.12613</RefLink>
      </Reference>
      <Reference refNo="9">
        <RefAuthor>&#379;&#243;&#322;kiewicz J</RefAuthor>
        <RefAuthor>Marzec A</RefAuthor>
        <RefAuthor>Ruszczy&#324;ski M</RefAuthor>
        <RefAuthor>Feleszko W</RefAuthor>
        <RefTitle>Postbiotics-A Step Beyond Pre- and Probiotics</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Nutrients</RefJournal>
        <RefPage>2189</RefPage>
        <RefTotal>&#379;&#243;&#322;kiewicz J, Marzec A, Ruszczy&#324;ski M, Feleszko W. Postbiotics-A Step Beyond Pre- and Probiotics. Nutrients. 2020 Jul 23;12(8):2189. DOI: 10.3390&#47;nu12082189</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;nu12082189</RefLink>
      </Reference>
      <Reference refNo="10">
        <RefAuthor>Aguilar-Toal&#225; J</RefAuthor>
        <RefAuthor>Garcia-Varela R</RefAuthor>
        <RefAuthor>Garcia H</RefAuthor>
        <RefAuthor>Mata-Haro V</RefAuthor>
        <RefAuthor>Gonz&#225;lez-C&#243;rdova A</RefAuthor>
        <RefAuthor>Vallejo-Cordoba B</RefAuthor>
        <RefAuthor>Hern&#225;ndez-Mendozaet A</RefAuthor>
        <RefTitle>Postbiotics: An evolving term within the functional foods field</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Trends Food Sci Technol</RefJournal>
        <RefPage>105-14</RefPage>
        <RefTotal>Aguilar-Toal&#225; J, Garcia-Varela R, Garcia H, Mata-Haro V, Gonz&#225;lez-C&#243;rdova A, Vallejo-Cordoba B, Hern&#225;ndez-Mendozaet A. Postbiotics: An evolving term within the functional foods field. Trends Food Sci Technol. 2018;75:105-14. DOI: 10.1016&#47;j.tifs.2018.03.009 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.tifs.2018.03.009</RefLink>
      </Reference>
      <Reference refNo="11">
        <RefAuthor>Abeysekera W</RefAuthor>
        <RefAuthor>Premakumara G</RefAuthor>
        <RefAuthor>Ratnasooriya W</RefAuthor>
        <RefTitle>In vitro antioxidant properties of leaf and bark extracts of ceylon cinnamon (Cinnamomum zeylanicum Blume)</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Trop Agricul Res</RefJournal>
        <RefPage>128-38</RefPage>
        <RefTotal>Abeysekera W, Premakumara G, Ratnasooriya W. In vitro antioxidant properties of leaf and bark extracts of ceylon cinnamon (Cinnamomum zeylanicum Blume). Trop Agricul Res. 2013;24(2):128-38. </RefTotal>
      </Reference>
      <Reference refNo="12">
        <RefAuthor>Hartmann HA</RefAuthor>
        <RefAuthor>Wilke T</RefAuthor>
        <RefAuthor>Erdmann R</RefAuthor>
        <RefTitle>Efficacy of bacteriocin-containing cell-free culture supernatants from lactic acid bacteria to control Listeria monocytogenes in food</RefTitle>
        <RefYear>2011</RefYear>
        <RefJournal>Int J Food Microbiol</RefJournal>
        <RefPage>192-9</RefPage>
        <RefTotal>Hartmann HA, Wilke T, Erdmann R. Efficacy of bacteriocin-containing cell-free culture supernatants from lactic acid bacteria to control Listeria monocytogenes in food. Int J Food Microbiol. 2011 Mar 30;146(2):192-9. DOI: 10.1016&#47;j.ijfoodmicro.2011.02.031</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ijfoodmicro.2011.02.031</RefLink>
      </Reference>
      <Reference refNo="13">
        <RefAuthor>Agrawal S</RefAuthor>
        <RefAuthor>Dufoss&#233; L</RefAuthor>
        <RefAuthor>Deshmukh SK</RefAuthor>
        <RefTitle>Antibacterial metabolites from an unexplored strain of marine fungi Emericellopsis minima and determination of the probable mode of action against Staphylococcus aureus and methicillin-resistant S. aureus</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>Biotechnol Appl Biochem</RefJournal>
        <RefPage>120-9</RefPage>
        <RefTotal>Agrawal S, Dufoss&#233; L, Deshmukh SK. Antibacterial metabolites from an unexplored strain of marine fungi Emericellopsis minima and determination of the probable mode of action against Staphylococcus aureus and methicillin-resistant S. aureus. Biotechnol Appl Biochem. 2023 Feb;70(1):120-9. DOI: 10.1002&#47;bab.2334</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1002&#47;bab.2334</RefLink>
      </Reference>
      <Reference refNo="14">
        <RefAuthor>Hossain MI</RefAuthor>
        <RefAuthor>Mizan MFR</RefAuthor>
        <RefAuthor>Roy PK</RefAuthor>
        <RefAuthor>Nahar S</RefAuthor>
        <RefAuthor>Toushik SH</RefAuthor>
        <RefAuthor>Ashrafudoulla M</RefAuthor>
        <RefAuthor>Jahid IK</RefAuthor>
        <RefAuthor>Lee J</RefAuthor>
        <RefAuthor>Ha SD</RefAuthor>
        <RefTitle>Listeria monocytogenes biofilm inhibition on food contact surfaces by application of postbiotics from Lactobacillus curvatus B.67 and Lactobacillus plantarum M.2</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Food Res Int</RefJournal>
        <RefPage>110595</RefPage>
        <RefTotal>Hossain MI, Mizan MFR, Roy PK, Nahar S, Toushik SH, Ashrafudoulla M, Jahid IK, Lee J, Ha SD. Listeria monocytogenes biofilm inhibition on food contact surfaces by application of postbiotics from Lactobacillus curvatus B.67 and Lactobacillus plantarum M.2. Food Res Int. 2021 Oct;148:110595. DOI: 10.1016&#47;j.foodres.2021.110595</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.foodres.2021.110595</RefLink>
      </Reference>
      <Reference refNo="15">
        <RefAuthor>Rajivgandhi GN</RefAuthor>
        <RefAuthor>Ramachandran G</RefAuthor>
        <RefAuthor>Kanisha CC</RefAuthor>
        <RefAuthor>Li J-L</RefAuthor>
        <RefAuthor>Yin L</RefAuthor>
        <RefAuthor>Manoharan N</RefAuthor>
        <RefAuthor>Alharbi NS</RefAuthor>
        <RefAuthor>Kadaikunnan S</RefAuthor>
        <RefAuthor>Khaled JM</RefAuthor>
        <RefAuthor>Li WJ</RefAuthor>
        <RefTitle>Anti-biofilm compound of 1, 4-diaza-2, 5-dioxo-3-isobutyl bicyclo &#91;4.3. 0&#93; nonane from marine Nocardiopsis sp. DMS 2 (MH900226) against biofilm forming K. pneumoniae</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>J King Saud Univ Sci</RefJournal>
        <RefPage>3495-502</RefPage>
        <RefTotal>Rajivgandhi GN, Ramachandran G, Kanisha CC, Li J-L, Yin L, Manoharan N, Alharbi NS, Kadaikunnan S, Khaled JM, Li WJ. Anti-biofilm compound of 1, 4-diaza-2, 5-dioxo-3-isobutyl bicyclo &#91;4.3. 0&#93; nonane from marine Nocardiopsis sp. DMS 2 (MH900226) against biofilm forming K. pneumoniae. J King Saud Univ Sci. 2020;32(8):3495-502. DOI: 10.1016&#47;j.jksus.2020.10.012</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jksus.2020.10.012</RefLink>
      </Reference>
      <Reference refNo="16">
        <RefAuthor>Zaman NR</RefAuthor>
        <RefAuthor>Chowdhury UF</RefAuthor>
        <RefAuthor>Reza RN</RefAuthor>
        <RefAuthor>Chowdhury FT</RefAuthor>
        <RefAuthor>Sarker M</RefAuthor>
        <RefAuthor>Hossain MM</RefAuthor>
        <RefAuthor>Akbor MA</RefAuthor>
        <RefAuthor>Amin A</RefAuthor>
        <RefAuthor>Islam MR</RefAuthor>
        <RefAuthor>Khan H</RefAuthor>
        <RefTitle>Plant growth promoting endophyte Burkholderia contaminans NZ antagonizes phytopathogen Macrophomina phaseolina through melanin synthesis and pyrrolnitrin inhibition</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>PLoS One</RefJournal>
        <RefPage>e0257863</RefPage>
        <RefTotal>Zaman NR, Chowdhury UF, Reza RN, Chowdhury FT, Sarker M, Hossain MM, Akbor MA, Amin A, Islam MR, Khan H. Plant growth promoting endophyte Burkholderia contaminans NZ antagonizes phytopathogen Macrophomina phaseolina through melanin synthesis and pyrrolnitrin inhibition. PLoS One. 2021 Sep 30;16(9):e0257863. DOI: 10.1371&#47;journal.pone.0257863</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1371&#47;journal.pone.0257863</RefLink>
      </Reference>
      <Reference refNo="17">
        <RefAuthor>Mehrnia MA</RefAuthor>
        <RefAuthor>Alizadeh Behbahani B</RefAuthor>
        <RefAuthor>Barzegar H</RefAuthor>
        <RefAuthor>Tanavar H</RefAuthor>
        <RefTitle>Sclerorhachis platyrachis essential oil: Antioxidant power, total phenolic and flavonoid content and its antimicrobial activity on some Gram-positive and Gram-negative bacteria &#8220;in vitro&#8221;</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>J Food Sci Technol (Iran)</RefJournal>
        <RefPage>189-98</RefPage>
        <RefTotal>Mehrnia MA, Alizadeh Behbahani B, Barzegar H, Tanavar H. Sclerorhachis platyrachis essential oil: Antioxidant power, total phenolic and flavonoid content and its antimicrobial activity on some Gram-positive and Gram-negative bacteria &#8220;in vitro&#8221;. J Food Sci Technol (Iran). 2021;18(112):189-98. DOI: 10.52547&#47;fsct.18.112.189 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.52547&#47;fsct.18.112.189</RefLink>
      </Reference>
      <Reference refNo="18">
        <RefAuthor>Zanganeh H</RefAuthor>
        <RefAuthor>Mortazavi SA</RefAuthor>
        <RefAuthor>Shahidi F</RefAuthor>
        <RefAuthor>Alizadeh Behbahani B</RefAuthor>
        <RefTitle>Evaluation of the chemical and antibacterial properties of Citrus paradise essential oil and its application in Lallemantia iberica seed mucilage edible coating to improve the physicochemical, microbiological and sensory properties of lamb during refrigerated storage</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>J Food Measur Characteriz</RefJournal>
        <RefPage>5556-71</RefPage>
        <RefTotal>Zanganeh H, Mortazavi SA, Shahidi F, Alizadeh Behbahani B. Evaluation of the chemical and antibacterial properties of Citrus paradise essential oil and its application in Lallemantia iberica seed mucilage edible coating to improve the physicochemical, microbiological and sensory properties of lamb during refrigerated storage. J Food Measur Characteriz. 2021;15(6):5556-71. DOI: 10.1007&#47;s11694-021-01129-9 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s11694-021-01129-9</RefLink>
      </Reference>
      <Reference refNo="19">
        <RefAuthor>Unlu M</RefAuthor>
        <RefAuthor>Ergene E</RefAuthor>
        <RefAuthor>Unlu GV</RefAuthor>
        <RefAuthor>Zeytinoglu HS</RefAuthor>
        <RefAuthor>Vural N</RefAuthor>
        <RefTitle>Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae)</RefTitle>
        <RefYear>2010</RefYear>
        <RefJournal>Food Chem Toxicol</RefJournal>
        <RefPage>3274-80</RefPage>
        <RefTotal>Unlu M, Ergene E, Unlu GV, Zeytinoglu HS, Vural N. Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae). Food Chem Toxicol. 2010 Nov;48(11):3274-80. DOI: 10.1016&#47;j.fct.2010.09.001</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.fct.2010.09.001</RefLink>
      </Reference>
      <Reference refNo="20">
        <RefAuthor>Zabala A</RefAuthor>
        <RefAuthor>Mart&#237;n MR</RefAuthor>
        <RefAuthor>Haza AI</RefAuthor>
        <RefAuthor>Fern&#225;ndez L</RefAuthor>
        <RefAuthor>Rodr&#237;guez JM</RefAuthor>
        <RefAuthor>Morales P</RefAuthor>
        <RefTitle>Anti-proliferative effect of two lactic acid bacteria strains of human origin on the growth of a myeloma cell line</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Lett Appl Microbiol</RefJournal>
        <RefPage>287-92</RefPage>
        <RefTotal>Zabala A, Mart&#237;n MR, Haza AI, Fern&#225;ndez L, Rodr&#237;guez JM, Morales P. Anti-proliferative effect of two lactic acid bacteria strains of human origin on the growth of a myeloma cell line. Lett Appl Microbiol. 2001 Apr;32(4):287-92. DOI: 10.1046&#47;j.1472-765x.2001.00910.x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1046&#47;j.1472-765x.2001.00910.x</RefLink>
      </Reference>
      <Reference refNo="21">
        <RefAuthor>Kerry RG</RefAuthor>
        <RefAuthor>Patra JK</RefAuthor>
        <RefAuthor>Gouda S</RefAuthor>
        <RefAuthor>Park Y</RefAuthor>
        <RefAuthor>Shin HS</RefAuthor>
        <RefAuthor>Das G</RefAuthor>
        <RefTitle>Benefaction of probiotics for human health: A review</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>J Food Drug Anal</RefJournal>
        <RefPage>927-39</RefPage>
        <RefTotal>Kerry RG, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: A review. J Food Drug Anal. 2018 Jul;26(3):927-39. DOI: 10.1016&#47;j.jfda.2018.01.002</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jfda.2018.01.002</RefLink>
      </Reference>
      <Reference refNo="22">
        <RefAuthor>Rad AH</RefAuthor>
        <RefAuthor>Abbasi A</RefAuthor>
        <RefAuthor>Kafil HS</RefAuthor>
        <RefAuthor>Ganbarov K</RefAuthor>
        <RefTitle>Potential Pharmaceutical and Food Applications of Postbiotics: A Review</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Curr Pharm Biotechnol</RefJournal>
        <RefPage>1576-87</RefPage>
        <RefTotal>Rad AH, Abbasi A, Kafil HS, Ganbarov K. Potential Pharmaceutical and Food Applications of Postbiotics: A Review. Curr Pharm Biotechnol. 2020;21(15):1576-87. DOI: 10.2174&#47;1389201021666200516154833</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2174&#47;1389201021666200516154833</RefLink>
      </Reference>
      <Reference refNo="23">
        <RefAuthor>Gourama H</RefAuthor>
        <RefTitle>Foodborne pathogens</RefTitle>
        <RefYear>2020</RefYear>
        <RefBookTitle>Food Safety Engineering</RefBookTitle>
        <RefPage>25-49</RefPage>
        <RefTotal>Gourama H. Foodborne pathogens. In: Demirci A, Feng H, Krishnamurthy K, editors. Food Safety Engineering. Cham, Switzerland: Springer; 2020. pp. 25-49.</RefTotal>
      </Reference>
      <Reference refNo="24">
        <RefAuthor>Qiu W</RefAuthor>
        <RefAuthor>Zhou Y</RefAuthor>
        <RefAuthor>Li Z</RefAuthor>
        <RefAuthor>Huang T</RefAuthor>
        <RefAuthor>Xiao Y</RefAuthor>
        <RefAuthor>Cheng L</RefAuthor>
        <RefAuthor>Peng X</RefAuthor>
        <RefAuthor>Zhang L</RefAuthor>
        <RefAuthor>Ren B</RefAuthor>
        <RefTitle>Application of Antibiotics&#47;Antimicrobial Agents on Dental Caries</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Biomed Res Int</RefJournal>
        <RefPage>5658212</RefPage>
        <RefTotal>Qiu W, Zhou Y, Li Z, Huang T, Xiao Y, Cheng L, Peng X, Zhang L, Ren B. Application of Antibiotics&#47;Antimicrobial Agents on Dental Caries. Biomed Res Int. 2020 Jan 31;2020:5658212. DOI: 10.1155&#47;2020&#47;5658212</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1155&#47;2020&#47;5658212</RefLink>
      </Reference>
      <Reference refNo="25">
        <RefAuthor>Keuchel M</RefAuthor>
        <RefAuthor>Bota M</RefAuthor>
        <RefAuthor>Baltes P</RefAuthor>
        <RefTitle>Infectious diseases affecting the small bowel - what not to miss</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Curr Opin Gastroenterol</RefJournal>
        <RefPage>255-66</RefPage>
        <RefTotal>Keuchel M, Bota M, Baltes P. Infectious diseases affecting the small bowel - what not to miss. Curr Opin Gastroenterol. 2021 May 1;37(3):255-66. DOI: 10.1097&#47;MOG.0000000000000720</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;MOG.0000000000000720</RefLink>
      </Reference>
      <Reference refNo="26">
        <RefAuthor>Mani-L&#243;pez E</RefAuthor>
        <RefAuthor>Arrioja-Bret&#243;n D</RefAuthor>
        <RefAuthor>L&#243;pez-Malo A</RefAuthor>
        <RefTitle>The impacts of antimicrobial and antifungal activity of cell-free supernatants from lactic acid bacteria in vitro and foods</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Compr Rev Food Sci Food Saf</RefJournal>
        <RefPage>604-41</RefPage>
        <RefTotal>Mani-L&#243;pez E, Arrioja-Bret&#243;n D, L&#243;pez-Malo A. The impacts of antimicrobial and antifungal activity of cell-free supernatants from lactic acid bacteria in vitro and foods. Compr Rev Food Sci Food Saf. 2022 Jan;21(1):604-41. DOI: 10.1111&#47;1541-4337.12872 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;1541-4337.12872</RefLink>
      </Reference>
      <Reference refNo="27">
        <RefAuthor>Akrami S</RefAuthor>
        <RefAuthor>Abouali R</RefAuthor>
        <RefAuthor>Olapour MM</RefAuthor>
        <RefAuthor>Abady RHL</RefAuthor>
        <RefAuthor>Yazdaninejad H</RefAuthor>
        <RefAuthor>Yousefi-Avarvand A</RefAuthor>
        <RefTitle>Bacterial etiology and antibiotic susceptibility pattern of female patients with urinary tract infection referred to Imam Khomeini Hospital, Ahvaz, Iran, 2019</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>J Curr Biomed Rep</RefJournal>
        <RefPage>23-6</RefPage>
        <RefTotal>Akrami S, Abouali R, Olapour MM, Abady RHL, Yazdaninejad H, Yousefi-Avarvand A. Bacterial etiology and antibiotic susceptibility pattern of female patients with urinary tract infection referred to Imam Khomeini Hospital, Ahvaz, Iran, 2019. J Curr Biomed Rep. 2020;1(1):23-6. DOI: 10.52547&#47;jcbior.1.1.23</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.52547&#47;jcbior.1.1.23</RefLink>
      </Reference>
      <Reference refNo="28">
        <RefAuthor>Kim S</RefAuthor>
        <RefAuthor>Kim GH</RefAuthor>
        <RefAuthor>Cho H</RefAuthor>
        <RefTitle>Postbiotics for cancer prevention and treatment</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Microbiol Soc Korea</RefJournal>
        <RefPage>142-53</RefPage>
        <RefTotal>Kim S, Kim GH, Cho H. Postbiotics for cancer prevention and treatment. Microbiol Soc Korea. 2021;57(3):142-53. DOI: 10.7845&#47;kjm.2021.1067 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.7845&#47;kjm.2021.1067</RefLink>
      </Reference>
      <Reference refNo="29">
        <RefAuthor>Warda AK</RefAuthor>
        <RefAuthor>Clooney AG</RefAuthor>
        <RefAuthor>Ryan F</RefAuthor>
        <RefAuthor>de Almeida Bettio PH</RefAuthor>
        <RefAuthor>Di Benedetto G</RefAuthor>
        <RefAuthor>Ross RP</RefAuthor>
        <RefAuthor>Hill C</RefAuthor>
        <RefTitle>A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in pure culture and in human fermented faecal communities</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Appl Environ Microbiol</RefJournal>
        <RefPage>e02459-20</RefPage>
        <RefTotal>Warda AK, Clooney AG, Ryan F, de Almeida Bettio PH, Di Benedetto G, Ross RP, Hill C. A postbiotic consisting of heat-treated lactobacilli has a bifidogenic effect in pure culture and in human fermented faecal communities. Appl Environ Microbiol. 2021 Apr 15;87(8):e02459-20. DOI: 10.1128&#47;AEM.02459-20</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1128&#47;AEM.02459-20</RefLink>
      </Reference>
      <Reference refNo="30">
        <RefAuthor>Kok CR</RefAuthor>
        <RefAuthor>Brabec B</RefAuthor>
        <RefAuthor>Chichlowski M</RefAuthor>
        <RefAuthor>Harris CL</RefAuthor>
        <RefAuthor>Moore N</RefAuthor>
        <RefAuthor>Wampler JL</RefAuthor>
        <RefAuthor>Vanderhoof J</RefAuthor>
        <RefAuthor>Rose D</RefAuthor>
        <RefAuthor>Hutkins R</RefAuthor>
        <RefTitle>Stool microbiome, pH and short&#47;branched chain fatty acids in infants receiving extensively hydrolyzed formula, amino acid formula, or human milk through two months of age</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>BMC Microbiol</RefJournal>
        <RefPage>337</RefPage>
        <RefTotal>Kok CR, Brabec B, Chichlowski M, Harris CL, Moore N, Wampler JL, Vanderhoof J, Rose D, Hutkins R. Stool microbiome, pH and short&#47;branched chain fatty acids in infants receiving extensively hydrolyzed formula, amino acid formula, or human milk through two months of age. BMC Microbiol. 2020 Nov 9;20(1):337. DOI: 10.1186&#47;s12866-020-01991-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12866-020-01991-5</RefLink>
      </Reference>
      <Reference refNo="31">
        <RefAuthor>Kotani Y</RefAuthor>
        <RefAuthor>Kunisawa J</RefAuthor>
        <RefAuthor>Suzuki Y</RefAuthor>
        <RefAuthor>Sato I</RefAuthor>
        <RefAuthor>Saito T</RefAuthor>
        <RefAuthor>Toba M</RefAuthor>
        <RefAuthor>Kohda N</RefAuthor>
        <RefAuthor>Kiyono H</RefAuthor>
        <RefTitle>Role of Lactobacillus pentosus Strain b240 and the Toll-like receptor 2 axis in Peyer&#39;s patch dendritic cell-mediated immunoglobulin A enhancement</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>PLoS One</RefJournal>
        <RefPage>e91857</RefPage>
        <RefTotal>Kotani Y, Kunisawa J, Suzuki Y, Sato I, Saito T, Toba M, Kohda N, Kiyono H. Role of Lactobacillus pentosus Strain b240 and the Toll-like receptor 2 axis in Peyer&#39;s patch dendritic cell-mediated immunoglobulin A enhancement. PLoS One. 2014 Mar 14;9(3):e91857. DOI: 10.1371&#47;journal.pone.0091857</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1371&#47;journal.pone.0091857</RefLink>
      </Reference>
      <Reference refNo="32">
        <RefAuthor>Falah F</RefAuthor>
        <RefAuthor>Shirani K</RefAuthor>
        <RefAuthor>Vasiee A</RefAuthor>
        <RefAuthor>Yazdi FT</RefAuthor>
        <RefAuthor>Behbahani BA</RefAuthor>
        <RefTitle>In vitro screening of phytochemicals, antioxidant, antimicrobial, and cytotoxic activity of Echinops setifer extract</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Biocatal Agricult Biotechnol</RefJournal>
        <RefPage>102102</RefPage>
        <RefTotal>Falah F, Shirani K, Vasiee A, Yazdi FT, Behbahani BA. In vitro screening of phytochemicals, antioxidant, antimicrobial, and cytotoxic activity of Echinops setifer extract. Biocatal Agricult Biotechnol. 2021; 35(6):102102. DOI: 10.1016&#47;j.bcab.2021.102102 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.bcab.2021.102102</RefLink>
      </Reference>
      <Reference refNo="33">
        <RefAuthor>Dilna SV</RefAuthor>
        <RefAuthor>Surya H</RefAuthor>
        <RefAuthor>Aswathy RG</RefAuthor>
        <RefAuthor>Varsha KK</RefAuthor>
        <RefAuthor>Sakthikumar DN</RefAuthor>
        <RefAuthor>Pandey A</RefAuthor>
        <RefAuthor></RefAuthor>
        <RefTitle>Characterization of an exopolysaccharide with potential health-benefit properties from a probiotic Lactobacillus plantarum RJF4</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>LWT-Food Sci Technol</RefJournal>
        <RefPage>1179-86</RefPage>
        <RefTotal>Dilna SV, Surya H, Aswathy RG, Varsha KK, Sakthikumar DN, Pandey A, et al. Characterization of an exopolysaccharide with potential health-benefit properties from a probiotic Lactobacillus plantarum RJF4. LWT-Food Sci Technol. 2015;64(2):1179-86. DOI: 10.1016&#47;j.lwt.2015.07.040 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.lwt.2015.07.040</RefLink>
      </Reference>
      <Reference refNo="34">
        <RefAuthor>Gezgin&#231; Y</RefAuthor>
        <RefAuthor>Karabekmez-Erdem T</RefAuthor>
        <RefAuthor>Tatar HD</RefAuthor>
        <RefAuthor>Ayman S</RefAuthor>
        <RefAuthor>Ganiyusufo&#287;lu E</RefAuthor>
        <RefAuthor>Dayisoylu KS</RefAuthor>
        <RefTitle>Health promoting benefits of postbiotics produced by lactic acid bacteria: Exopolysaccharide</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Biotech Studies</RefJournal>
        <RefPage>61-70</RefPage>
        <RefTotal>Gezgin&#231; Y, Karabekmez-Erdem T, Tatar HD, Ayman S, Ganiyusufo&#287;lu E, Dayisoylu KS. Health promoting benefits of postbiotics produced by lactic acid bacteria: Exopolysaccharide. Biotech Studies. 2022;31(2):61-70. DOI: 10.38042&#47;biotechstudies.1159166 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.38042&#47;biotechstudies.1159166</RefLink>
      </Reference>
      <Reference refNo="35">
        <RefAuthor>Deepak V</RefAuthor>
        <RefAuthor>Ramachandran S</RefAuthor>
        <RefAuthor>Balahmar RM</RefAuthor>
        <RefAuthor>Pandian SR</RefAuthor>
        <RefAuthor>Sivasubramaniam SD</RefAuthor>
        <RefAuthor>Nellaiah H</RefAuthor>
        <RefAuthor>Sundar K</RefAuthor>
        <RefTitle>In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>In Vitro Cell Dev Biol Anim</RefJournal>
        <RefPage>163-73</RefPage>
        <RefTotal>Deepak V, Ramachandran S, Balahmar RM, Pandian SR, Sivasubramaniam SD, Nellaiah H, Sundar K. In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines. In Vitro Cell Dev Biol Anim. 2016 Feb;52(2):163-73. DOI: 10.1007&#47;s11626-015-9970-3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s11626-015-9970-3</RefLink>
      </Reference>
      <Reference refNo="36">
        <RefAuthor>Barros CP</RefAuthor>
        <RefAuthor>Guimaraes JT</RefAuthor>
        <RefAuthor>Esmerino EA</RefAuthor>
        <RefAuthor>Duarte MCK</RefAuthor>
        <RefAuthor>Silva MC</RefAuthor>
        <RefAuthor>Silva R</RefAuthor>
        <RefAuthor>Ferreira BM</RefAuthor>
        <RefAuthor>Sant&#8217;Ana AS</RefAuthor>
        <RefAuthor>Freitas MQ</RefAuthor>
        <RefAuthor>Cruz AG</RefAuthor>
        <RefTitle>Paraprobiotics and postbiotics: concepts and potential applications in dairy products</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Curr Opin Food Sci</RefJournal>
        <RefPage>1-8</RefPage>
        <RefTotal>Barros CP, Guimaraes JT, Esmerino EA, Duarte MCK, Silva MC, Silva R, Ferreira BM, Sant&#8217;Ana AS, Freitas MQ, Cruz AG. Paraprobiotics and postbiotics: concepts and potential applications in dairy products. Curr Opin Food Sci. 2020;32:1-8.</RefTotal>
      </Reference>
      <Reference refNo="37">
        <RefAuthor>Ahmad Rather I</RefAuthor>
        <RefAuthor>Seo BJ</RefAuthor>
        <RefAuthor>Rejish Kumar VJ</RefAuthor>
        <RefAuthor>Choi UH</RefAuthor>
        <RefAuthor>Choi KH</RefAuthor>
        <RefAuthor>Lim JH</RefAuthor>
        <RefAuthor>Park YH</RefAuthor>
        <RefTitle>Isolation and characterization of a proteinaceous antifungal compound from Lactobacillus plantarum YML007 and its application as a food preservative</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Lett Appl Microbiol</RefJournal>
        <RefPage>69-76</RefPage>
        <RefTotal>Ahmad Rather I, Seo BJ, Rejish Kumar VJ, Choi UH, Choi KH, Lim JH, Park YH. Isolation and characterization of a proteinaceous antifungal compound from Lactobacillus plantarum YML007 and its application as a food preservative. Lett Appl Microbiol. 2013 Jul;57(1):69-76. DOI: 10.1111&#47;lam.12077</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;lam.12077</RefLink>
      </Reference>
      <Reference refNo="38">
        <RefAuthor>Eghbal N</RefAuthor>
        <RefAuthor>Chihib NE</RefAuthor>
        <RefAuthor>Gharsallaoui A</RefAuthor>
        <RefTitle>Nisin</RefTitle>
        <RefYear>2020</RefYear>
        <RefBookTitle>Antimicrobials in Food</RefBookTitle>
        <RefPage>309-38</RefPage>
        <RefTotal>Eghbal N, Chihib NE, Gharsallaoui A. Nisin. In: Davidson PM, Taylor TM, David JRD, editors. Antimicrobials in Food. Boca Raton, FL: CRC Press; 2020. pp. 309-38. DOI: 10.1201&#47;9780429058196</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1201&#47;9780429058196</RefLink>
      </Reference>
      <Reference refNo="39">
        <RefAuthor>Lee J</RefAuthor>
        <RefAuthor>Seto D</RefAuthor>
        <RefAuthor>Bielory L</RefAuthor>
        <RefTitle>Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis</RefTitle>
        <RefYear>2008</RefYear>
        <RefJournal>J Allergy Clin Immunol</RefJournal>
        <RefPage>116-21</RefPage>
        <RefTotal>Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008 Jan;121(1):116-21.e11. DOI: 10.1016&#47;j.jaci.2007.10.043</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jaci.2007.10.043</RefLink>
      </Reference>
      <Reference refNo="40">
        <RefAuthor>Elham N</RefAuthor>
        <RefAuthor>Naheed M</RefAuthor>
        <RefAuthor>Elahe M</RefAuthor>
        <RefAuthor>Hossein MM</RefAuthor>
        <RefAuthor>Majid T</RefAuthor>
        <RefTitle>Selective cytotoxic effect of probiotic, paraprobiotic and postbiotics of L. casei strains against colorectal cancer cells: In vitro studies</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Braz J Pharmaceut Sci</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Elham N, Naheed M, Elahe M, Hossein MM, Majid T. Selective cytotoxic effect of probiotic, paraprobiotic and postbiotics of L. casei strains against colorectal cancer cells: In vitro studies. Braz J Pharmaceut Sci. 2022;58(4). DOI: 10.1590&#47;s2175-97902022e19400</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1590&#47;s2175-97902022e19400</RefLink>
      </Reference>
      <Reference refNo="41">
        <RefAuthor>Er S</RefAuthor>
        <RefAuthor>Koparal AT</RefAuthor>
        <RefAuthor>Kivanc M</RefAuthor>
        <RefTitle>Cytotoxic effects of various lactic acid bacteria on Caco-2 cells</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Turk J Biol</RefJournal>
        <RefPage>23-30</RefPage>
        <RefTotal>Er S, Koparal AT, Kivanc M. Cytotoxic effects of various lactic acid bacteria on Caco-2 cells. Turk J Biol. 2015;39(1):23-30. DOI: 10.3906&#47;biy-1402-62 </RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3906&#47;biy-1402-62</RefLink>
      </Reference>
      <Reference refNo="42">
        <RefAuthor>Faghfoori Z</RefAuthor>
        <RefAuthor>Gargari BP</RefAuthor>
        <RefAuthor>Gharamaleki AS</RefAuthor>
        <RefAuthor>Bagherpour H</RefAuthor>
        <RefAuthor>Khosroushahi AY</RefAuthor>
        <RefTitle>Cellular and molecular mechanisms of probiotics effects on colorectal cancer</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>J FunctFoods</RefJournal>
        <RefPage>463-72</RefPage>
        <RefTotal>Faghfoori Z, Gargari BP, Gharamaleki AS, Bagherpour H, Khosroushahi AY. Cellular and molecular mechanisms of probiotics effects on colorectal cancer. J FunctFoods. 2015;18(Suppl. 1):463-72. DOI: 10.1016&#47;j.jff.2015.08.013</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jff.2015.08.013</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <Table format="png">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption><Pgraph><Mark1>Table 1: Chemical composition of PLC identified and quantified by GC&#47;MS</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>2</MediaNo>
          <MediaID>2</MediaID>
          <Caption><Pgraph><Mark1>Table 2: The mean inhibition zone diameter (mm) of PLC for some pathogenic microorganisms by disc diffusion agar (DDA) method</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>3</MediaNo>
          <MediaID>3</MediaID>
          <Caption><Pgraph><Mark1>Table 3: The well-diffusion agar (WDA), minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the PLC on some pathogenic microorganisms</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>4</MediaNo>
          <MediaID>4</MediaID>
          <Caption><Pgraph><Mark1>Table 4: Minimal effective concentration (MEC) (mg&#47;mL) of the PLC on </Mark1><Mark1><Mark2>E. coli</Mark2></Mark1><Mark1> and </Mark1><Mark1><Mark2>L. monocytogenes</Mark2></Mark1><Mark1> in whole milk, ground meat and culture media</Mark1></Pgraph></Caption>
        </Table>
        <NoOfTables>4</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <Figure format="png" height="42" width="355">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <AltText>Equation 1</AltText>
        </Figure>
        <Figure format="png" height="40" width="273">
          <MediaNo>2</MediaNo>
          <MediaID>2</MediaID>
          <AltText>Equation 2</AltText>
        </Figure>
        <NoOfPictures>2</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>